Only show
results from:

Sort results by:

Display preferences
36 results sorted by relevancy Results per page:
AdnaGen AG Completes Successful Financial Restructuring.
Business Wire; May 4, 2009; 700+ Words ...balance sheet SAN ANTONIO, Texas and HANOVER, Germany -- AdnaGen AG announced today the completion of its debt restructuring efforts. AdnaGen AG, developer and marketer of blood test diagnostics kits...
AdnaGen AG and OncoVista Innovative Therapies Inc., Announce the Issuance in the U.S. of a Key Patent Related to Technology for the Detection and Analysis of Circulating Tumor Cells.
Cancer Weekly; Apr 7, 2009; 700+ Words AdnaGen AG, a molecular diagnostics company, and...large excess of unrelated cells (see also AdnaGen AG). A corresponding European Patent EP...treatment than was previously possible. AdnaGen AG has developed, and is marketing in Europe...
OncoVista Acquires Controlling Interest in AdnaGen AG.
Business Wire; Feb 23, 2006; 700+ Words ...Germany -- OncoVista, Inc. ("OncoVista") has acquired a controlling interest in AdnaGen AG ("AdnaGen"), based in Langenhagen, Germany. AdnaGen has developed and is marketing novel tests for the early detection and analysis of circulating...
Sysmex Europe GmbH to distribute products for the analysis of circulating tumor cells in different tumor entities developed by AdnaGen AG, a subsidiary of OncoVista Innovative Therapies Inc.
Business Wire; Jan 29, 2009; 700+ Words ...Germany -- Sysmex Europe GmbH and AdnaGen AG announced today that they have entered...agreement for all current and future AdnaGen proprietary CE-certified diagnostics...An advantage of the proprietary AdnaGen tests is versatility; the detection...
OncoVista, Inc. Increases Ownership of AdnaGen AG.
Business Wire; Jun 18, 2008; 693 Words ...successfully completed the acquisition of additional shares of AdnaGen AG (Hanover, Germany), increasing its ownership from...marketing approval for the AdnaGen tests in the US. About AdnaGen AG AdnaGen was founded in 1999 as a privately held biotechnology...
OncoVista Increases Its Share in AdnaGen AG.
Business Wire; Dec 17, 2007; 700+ Words ...acquisition of additional shares of AdnaGen AG (Hanover, Germany), increasing...outstanding shares of the company. AdnaGen AG has developed a proprietary method...utility of its breast cancer CTC test. AdnaGen AG is based in Hanover, Germany. The...
Innogenetics options AdnaGen's prenatal testing technology.(Innogenetics NV evaluation agreement with AdnaGen AG of Langenhagen)(Brief article)
Pharma Marketletter; Oct 2, 2006; 602 Words Ghent, Belgium-based drugmaker Innogenetics NV has entered into an exclusive option and evaluation agreement with AdnaGen AG of Langenhagen, Germany, on a technology to selectively and specifically isolate fetal red blood cells circulating...
OncoVista Innovative Therapies, Inc. Announces the Initiation of Clinical Development of AdnaGen's Breast Cancer Circulating Tumor Cells (CTCs) Diagnostic Technology in Women with High-Risk Locally Advanced Breast Cancer.(Clinical report)
Business Wire; Jul 23, 2009; 700+ Words ...Inc. ("OncoVista") (OTC BB: OVIT.OB) and AdnaGen Ag announced that The University of Texas M. D. Anderson...com. OncoVista, Inc. is the majority owner of AdnaGen, AG. About AdnaGen AG AdnaGen is a privately-held biotechnology company...
Lab21 Ltd to Provide AdnaGen's CE-Marked System for the Detection and Analysis of Circulating Tumor Cells CTCs in the United Kingdom and Ireland.(Company overview)
Cancer Weekly; Aug 25, 2009; 700+ Words Lab21 Ltd and AdnaGen AG announced that they have entered into...service and distribution agreement for AdnaGen's proprietary CE-certified circulating...biomarkers using RT-PCR. The proprietary AdnaGen approach has the clear advantage that...
OncoVista Innovative Therapies, Inc. Announces Appointment of AdnaGen Chief Executive Officer.
Business Wire; Apr 11, 2008; 700+ Words ...Rodatz as Chief Executive Officer of AdnaGen, effective April 1, 2008. OncoVista...Therapies currently owns 85% of AdnaGen AG, a privately-held German diagnostic...blood. The Company is utilizing the AdnaGen technology to drive its efforts to...
Lab21 Ltd to Provide AdnaGen's CE-Marked System for the Detection and Analysis of Circulating Tumor Cells (CTCs) in the United Kingdom and Ireland.
Business Wire; Aug 10, 2009; 700+ Words ...ANTONIO, Texas -- Lab21 Ltd and AdnaGen AG announced today that they have entered...service and distribution agreement for AdnaGen's proprietary CE-certified circulating...using RT-PCR. The proprietary AdnaGen approach has the clear advantage...
Lab21 to Supply AdnaGen's CE-Marked System for the Detection and Analysis of CTCs in the UK and Ireland.
Health & Beauty Close-Up; Aug 12, 2009; 700+ Words Lab21 and AdnaGen AG announced that they have entered into...service and distribution agreement for AdnaGen's proprietary CE-certified circulating...biomarkers using RT-PCR. The proprietary AdnaGen approach has the clear advantage that...
OncoVista Innovative Therapies and AdnaGen to Collaborate with M. D. Anderson Cancer Center
Wireless News; Jul 28, 2009; 417 Words ...OncoVista Innovative Therapies and AdnaGen to Collaborate with M. D. Anderson...Innovative Therapies, Inc. and AdnaGen Ag announced that The University of...collaborate on clinical studies of AdnaGen's molecular based CTC technology...
OncoVista Innovative Therapies, AdnaGen and M. D. Anderson Cancer Center to Collaborate.(Clinical report)
Health & Beauty Close-Up; Jul 27, 2009; 654 Words ...Innovative Therapies, Inc. and AdnaGen Ag announced that The University of...collaborate on clinical studies of AdnaGen's molecular based CTC technology...will conduct clinical trials for the AdnaGen Breast Select & Detect molecular...
OncoVista (OVIT) AdnaGen Test Identifies Cancer Stem Cells in the Bloodstream.
Business Wire; Nov 10, 2009; 700+ Words ...s wholly owned German subsidiary AdnaGen AG, is presently commercially available...conjunction with its subsidiary, AdnaGen AG which is based in Langenhagen Germany...the-art molecular platform of AdnaGen AG. Further information on OncoVista...
OncoVista: AdnaGen Test Identifies Cancer Stem Cells in the Bloodstream
Wireless News; Nov 13, 2009; 585 Words Wireless News 11-13-2009 OncoVista: AdnaGen Test Identifies Cancer Stem Cells in the BloodstreamType...developed and produced by OncoVista's German subsidiary AdnaGen AG, is presently commercially available and CE marked in...
OncoVista Innovative Therapies, Inc. Announces the Initiation of Clinical Development of AdnaGen's Breast Cancer Circulating Tumor Cells CTCs Diagnostic Technology in Women with High-Risk Locally Advanced Breast Cancer.(Clinical report)
Cancer Weekly; Aug 4, 2009; 700+ Words ...Therapies, Inc. ("OncoVista") (OTC BB: OVIT.OB) and AdnaGen Ag announced that The University of Texas M. D. Anderson Cancer Center will collaborate on clinical studies of AdnaGen's molecular based CTC technology in Women with High...
OncoVista: AdnaGen Test Identifies Cancer Stem Cells in the Bloodstream.
Health & Beauty Close-Up; Nov 13, 2009; 700+ Words ...Cancer Research. The Company's AdnaTest BreastCancer product developed and produced by OncoVista's German subsidiary AdnaGen AG, is presently commercially available and CE marked in Europe. The researchers were testing the theory that cancer cells...
OncoVista (OVIT.PK) Reports 179% Increase in 3Q Revenues Due to Subsidiary's Proprietary Branded Products and R&D Revenues.
Business Wire; Nov 19, 2009; 700+ Words ...consortium of biotech companies of which AdnaGen AG is a member. (BioRN was selected...conjunction with its subsidiary, AdnaGen AG which is based in Langenhagen, Germany...the-art molecular platform of AdnaGen AG. Further information on OncoVista...
OncoVista (OVIT.PK) Reports 287% Increase in 2Q Revenues Due to Subsidiary's Proprietary Branded Products.
Business Wire; Nov 5, 2009; 700+ Words ...proprietary products of our subsidiary, AdnaGen AG, are presently sold in ten countries...conjunction with its subsidiary, AdnaGen AG which is based in Langenhagen Germany...the-art molecular platform of AdnaGen AG. Further information on OncoVista...
36 results: 1 | 2

Find articles, research, and archives